3rd Circ. Revives Trade Secrets Suit Against Aurobindo

Law360 (June 8, 2021, 7:00 PM EDT) -- The Third Circuit revived a pharmaceutical laboratory's trade secrets lawsuit against a former executive and Aurobindo Pharma units on Tuesday, ruling that a district court applied an improperly heavy burden on the lab to establish the proprietary information at issue and show how it was misused.

In a precedential decision clarifying pleading standards of trade secrets misappropriation claims, a three-judge panel said the allegations in Oakwood Laboratories LLC's third amended complaint were sufficient under the Defend Trade Secrets Act. Oakwood claimed its former vice president of product development defected to Aurobindo with information about Oakwood's microsphere products, which are sustained-release drug...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!